Jump to ContentJump to Main Navigation
A Decade of HAART
Users without a subscription are not able to see the full content.

A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy

José M. Zuniga, Alan Whiteside, Amin Ghaziani, and John G. Bartlett


Highly active antiretroviral therapy (HAART) is a therapeutic intervention developed by clinicians and researchers in order to fight the HIV pandemic. It has contributed to a significant reduction in AIDS-related mortality and allowed many previously bed-ridden patients to live healthier, more productive lives. Until the advent of HAART in 1996, a diagnosis of HIV infection was considered a death sentence. A decade later, the disease has been transformed into a serious, yet potentially manageable, medical condition for thousands of people living with HIV/AIDS in the developed world — almost ov ... More

Keywords: HAART, HIV, AIDS, highly active antiretroviral therapy, HIV treatment

Bibliographic Information

Print publication date: 2008 Print ISBN-13: 9780199225859
Published to Oxford Scholarship Online: September 2009 DOI:10.1093/acprof:oso/9780199225859.001.0001


Affiliations are at time of print publication.

José M. Zuniga, editor
President/CEO, International Association of Physicians in AIDS Care, Chicago, USA

Alan Whiteside, editor
Director, Health and Economics and HIV/AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa

Amin Ghaziani, editor
Cotsen Postdoctoral Fellow, Society of Fellows, Princeton University, USA


Subscriber Login

Forgotten your password?



Part 1 A decade of HAART: trials, tribulations and successes

Part 2 HAART in high human development countries

Part 3 HAART in medium human development countries

Part 4 HAART in low human development countries

Part 5 Future challenges in the next decade of HAART

End Matter